Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05619809 · ClinicalTrials.gov registry record · NA
Chronic Thermogenic Dietary Supplement Consumption
A NA study of Body Weight Changes and Metabolism Changes, sponsored by Texas Tech University.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT05619809: Completed NA study of Body Weight Changes and Metabolism Changes, sponsored by Texas Tech University.
NCT05619809 is a NA study of Body Weight Changes and Metabolism Changes that has completed, run by Texas Tech University. The registered enrollment target is 52 participants, below the 67-participant average among 11 other Body Weight Changes trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05619809, a NA study of Body Weight Changes and Metabolism Changes, has completed, sponsored by Texas Tech University.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a randomized, double-blind, placebo-controlled trial. Healthy, exercising adult males and females will be recruited for participation. After providing informed consent, each participant will be randomized to one of three groups: 1) OxyShred thermogenic fat burner; 2) Placebo (PL); and 3) Control. All participants will complete a baseline laboratory visit consisting of assessments of body composition, anthropometry, metabolism, hemodynamics, dietary intake, exercise habits, and subjective variables. Participants in the two intervention groups (i.e., OxyShred and PL) will then be given dietary supplements for daily consumption, including OxyShred/PL and protein powder. Participants in all groups will complete the 4-week study and follow their usual training and nutrition habits - besides increased protein intake in the OxyShred and PL groups - along with questionnaires to assess compliance with the study protocol and potential side effects of supplementation. Following this 4-week period, participants will complete a second laboratory visit, where all baseline assessments will be repeated. The effects of group (OxyShred, PL, and control) and time (baseline, 4 weeks) will be statistically examined using linear models, along with appropriate post-hoc tests.
Primary Outcome
Total body fat percentage from dual-energy x-ray absorptiometry
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo supplement
- DIETARY_SUPPLEMENT Protein supplement
- DIETARY_SUPPLEMENT Thermogenic dietary supplement
Study Locations (1)
Texas
- Department of Kinesiology & Sport Management - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2023-01-17 |
| Est. Completion | 2023-05-15 |
| Phase | NA |
What the finished NCT05619809 record still lists
NCT05619809 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 67-participant average among 11 other Body Weight Changes trials with a reported enrollment target (22% lower).
The record links to 5 conditions, with Body Weight Changes appearing as the primary indexed condition, and to 3 interventions - of which Placebo supplement is the first listed.
NCT05619809 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05619809 about?
NCT05619809 is a clinical study titled "Chronic Thermogenic Dietary Supplement Consumption". This study is a randomized, double-blind, placebo-controlled trial. Healthy, exercising adult males and females will be recruited for participation. After providing informed consent, each participant will be randomized to one of three groups: 1) OxyShred thermogenic fat burner; 2) Placebo (PL); and ...
What is the current status of trial NCT05619809?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2023-01-17. Estimated completion is 2023-05-15.
What conditions does trial NCT05619809 study?
This clinical trial studies the following conditions: Body Weight Changes, Metabolism Changes, Body Composition Changes, Anthropometric Changes, Hemodynamic Changes.
What interventions are being tested in trial NCT05619809?
The interventions under investigation include: Placebo supplement (DIETARY_SUPPLEMENT), Protein supplement (DIETARY_SUPPLEMENT), Thermogenic dietary supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05619809?
This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05619809 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Body Weight Changes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05619809's enrollment target sits among peer trials
52 9th of 11 higher than 3 of 11 other Body Weight Changes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Body Weight Changes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Precision Nutrition New York Study
RECRUITING · NA
-
Whole Foods for Teens: A Pilot Dietary Intervention to Reduce Body Adiposity in Adolescents With Obesity
RECRUITING · NA
-
Microalgae Extract Phaeosol Combined to Exercise in Healthy Overweight Women : Efficacy on Body Weight Management
COMPLETED · NA
-
Evaluate the Effects of Repeated Periods of Modified Fasting to Support Healthy Natural Weight Management and Prevention of Weight Gain
COMPLETED · NA
-
Diabetes Risk Education and Communication Trial
COMPLETED · NA
-
Whey Protein Supplementation in High School Athletes
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI